The protection estimate there is actually about what is claimed for many of the specific SARS-CoV-2 vaccines. It's probably better than some of the Russian and Chinese products.
As someone with clinical research experience, I tend to prefer "participants". "Subjects" does sound icky, and IRBs usually prohibit "patients" because of the need to separate standards of care from research trials. Agreed with you that "volunteers" is an oversimplification and a lot of people aren't really volunteering, especially in oncology research where my experience is from.
Interesting. More evidence that non-coronavirus vaccination can provide protection from COVID-19.
https://www.nature.com/articles/d41586-022-01315-9
The protection estimate there is actually about what is claimed for many of the specific SARS-CoV-2 vaccines. It's probably better than some of the Russian and Chinese products.
As someone with clinical research experience, I tend to prefer "participants". "Subjects" does sound icky, and IRBs usually prohibit "patients" because of the need to separate standards of care from research trials. Agreed with you that "volunteers" is an oversimplification and a lot of people aren't really volunteering, especially in oncology research where my experience is from.